These data suggest that the inhibition of STAT3 in the primary site is critical to reducing tumor cell growth, but in distant metastatic sites, such as the bone marrow, STAT3 inactivation could lead to the awakening of dormant tumor cells. Here, STAT3 is linked to neoplasm.